339 Clinical outcome and prognostic factors of patients (pts) with relapsed mesothelioma on phase I trials in the Drug Development Unit (DDU) of the Royal Marsden Hospital (RMH). (September 2015) - Papadatos-Pastos, D.; Roda, D.; Luken, M. De Miguel; Jalil, A.; Diamantis, N.; Michalarea, V.; Lima, J.; Capelan, M.; Bodla, S.; Bhosle, J.; Molife, R.; O'Brien, M.; et al.